Neeraj Vij Selected Research

Obstructive Lung Diseases (Obstructive Lung Disease)

12/2021	Early Diagnosis and Real-Time Monitoring of Regional Lung Function Changes to Prevent Chronic Obstructive Pulmonary Disease Progression to Severe Emphysema.
1/2020	Synthesis and Evaluation of Airway-Targeted PLGA-PEG Nanoparticles for Drug Delivery in Obstructive Lung Diseases.
1/2020	Synthesis and Evaluation of Dendrimers for Autophagy Augmentation and Alleviation of Obstructive Lung Diseases.
1/2017	Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
11/2016	Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases.
1/2012	Synthesis and evaluation of airway targeted PLGA nanoparticles for drug delivery in obstructive lung diseases.
9/2011	Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.
1/2011	Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neeraj Vij Research Topics

Disease

17	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 12/2009
16	Cystic Fibrosis (Mucoviscidosis) 01/2019 - 03/2006
14	Inflammation (Inflammations) 01/2021 - 01/2005
14	Emphysema 01/2019 - 01/2011
12	Lung Diseases (Lung Disease) 02/2021 - 04/2010
8	Obstructive Lung Diseases (Obstructive Lung Disease) 12/2021 - 01/2011
6	Infections 01/2019 - 10/2004
4	Neoplasms (Cancer) 01/2016 - 03/2006
3	Fibrosis (Cirrhosis) 09/2011 - 06/2006
2	Wounds and Injuries (Trauma) 05/2022 - 01/2005
2	Pain (Aches) 01/2021 - 09/2020
2	Asthma (Bronchial Asthma) 01/2020 - 01/2012
2	Bacterial Infections (Bacterial Infection) 01/2019 - 01/2017
2	Pseudomonas Infections 01/2019 - 01/2017
2	Pneumonia (Pneumonitis) 04/2017 - 01/2009
2	Fuchs' Endothelial Dystrophy 03/2013 - 12/2011
2	Sepsis (Septicemia) 03/2011 - 11/2010
1	Hypophosphatasia 05/2022
1	Congenital Abnormalities (Deformity) 04/2022
1	Low Back Pain (Lumbago) 06/2021
1	Radial Neuropathy (Saturday Night Palsy) 02/2021
1	Piriformis Muscle Syndrome 02/2021
1	Vitamin D Deficiency 01/2021
1	Osteoarthritis 01/2021
1	Knee Osteoarthritis 01/2021
1	Chronic Pain 09/2020
1	Weight Loss (Weight Reduction) 09/2020
1	Opioid-Related Disorders (Opiate Addiction) 09/2020
1	Postoperative Pain 09/2020
1	Airway Obstruction (Choking) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016

Drug/Important Bio-Agent (IBA)

18	SmokeIBA 12/2021 - 12/2009
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2004
11	Pharmaceutical PreparationsIBA 01/2020 - 09/2010
7	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2020 - 01/2011
6	CytokinesIBA 01/2018 - 01/2005
5	LipidsIBA 05/2015 - 01/2009
4	Dendrimers (Dendrons)IBA 01/2020 - 01/2016
4	ChloridesIBA 01/2019 - 03/2006
4	CeramidesIBA 01/2019 - 01/2011
4	Interleukin-8 (Interleukin 8)IBA 04/2010 - 06/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2011
3	AntioxidantsIBA 01/2019 - 12/2009
3	Cysteamine (Mercaptamine)FDA Link 01/2019 - 12/2017
3	Peroxidase (Myeloperoxidase)IBA 01/2018 - 01/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 11/2010
3	InterleukinsIBA 09/2017 - 09/2007
3	Valosin Containing ProteinIBA 07/2017 - 06/2011
3	LumicanIBA 09/2007 - 05/2004
2	SphingolipidsIBA 01/2019 - 05/2015
2	LipopolysaccharidesIBA 01/2018 - 09/2007
2	Ubiquitinated ProteinsIBA 09/2017 - 06/2011
2	GoldIBA 09/2017 - 06/2011
2	Caspase 3 (Caspase-3)IBA 09/2017 - 07/2017
2	fisetinIBA 07/2017 - 01/2017
2	Nicotine FDA Link 01/2017 - 01/2016
2	Nanoparticle Drug Delivery SystemIBA 11/2016 - 09/2011
2	CollagenIBA 03/2013 - 12/2011
2	SodiumIBA 03/2013 - 11/2008
2	GlucocorticoidsIBA 01/2012 - 02/2008
2	Deubiquitinating EnzymesIBA 06/2011 - 04/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2011 - 12/2009
2	NF-kappa B (NF-kB)IBA 04/2010 - 02/2008
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 05/2022
1	Air Pollutants (Pollutants, Air)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Parathyroid Hormone (Parathormone)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 09/2020
1	SphingosineIBA 01/2019
1	CystamineIBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2017
1	S-NitrosoglutathioneIBA 09/2017
1	3-nitrotyrosineIBA 09/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2017
1	Hematoxylin (Haematoxylon)IBA 07/2017
1	Transcription Factors (Transcription Factor)IBA 07/2017
1	Gemfibrozil (Lopid)FDA LinkGeneric 07/2017
1	3- ((3- trifluoromethyl)phenyl)- 5- ((3- carboxyphenyl)methylene)- 2- thioxo- 4- thiazolidinoneIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Expectorants (Mucolytics)IBA 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 11/2016

Therapy/Procedure

3	Therapeutics 06/2021 - 02/2008
2	Conservative Treatment 02/2021 - 02/2021
1	Braces 04/2022
1	Radiofrequency Ablation 06/2021
1	Viscosupplementation 01/2021
1	Complementary Therapies (Alternative Medicine) 09/2020
1	Elective Surgical Procedures 09/2020
1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2020
1	Physical Therapy Modalities (Physical Therapy Technique) 09/2020
1	Spinal Cord Stimulation 09/2020
1	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2020